Description
Clinical Dilemmas in Diabetes provides evidence-based clinical guidance on the most common and problematic areas of concern encountered in diagnosing, treating and managing patients with diabetes. Each chapter is highly topical and has been selected due to current interest, specific recent developments, and areas of controversy.
This valuable guide provides assistance in managing the life-long treatment of diabetes and the complications that often develop in patients. Clinical Dilemmas in Diabetes guides the medical team in their decision-making, particularly when there are conflicts in the treatment for the disease and the complications.
Part of the Clinical Dilemmas series, the well-focused chapter structure allows for quick retrieval of information, and each opens with a “Learning Points” box to aid easy assimilation of the main issues. With a leading team of contributors and editors, Professor Robert A. Rizza is the immediate Past-President of the American Diabetes Association.
This book is perfect for use on the wards and clinics as well as for self-study by diabetologists, diabetes specialist nurses, endocrinologists, GPs and cardiologists.
Table of Contents
Contributors.
Preface.
Part I Prediabetes and the Diagnosis of Diabetes.
1 Is prediabetes a risk factor or is it a disease? (Kalpana Muthusamy and Adrian Vella).
2 Early diagnosis of type 1 diabetes: Useful or a phyrrhic victory? (Chiara Guglielmi and Paolo Pozzilli).
3 How should secondary causes of diabetes be excluded? (Aonghus O'Loughlin and Sean F. Dinneen).
4 Screening patients with prediabetes and diabetes for cardiovascular disease (Deepika S. Reddy and Vivian Fonseca).
Part II Initial Evaluation and Management of Diabetes.
5 What is the role of self-monitoring in diabetes? Is there a role for postprandial glucose monitoring? How does continuous glucose monitoring integrate into clinical practice? (Rami Almokayyad and Robert Cuddihy).
6 The optimal diet for diabetes is? (Maria L. Collazo-Clavell).
7 How to determine when to pursue lifestyle change alone versus pharmacotherapy at diagnosis? (Galina Smushkin and F. John Service).
8 Insulin sensitizers versus secretagogues as first-line therapy for diabetes: Rationale for clinical choice (Robert J. Richards, L. Yvonne Melendez-Ramirez, and William T. Cefalu).
9 Are insulin sensitizers useful additions to insulin therapy? (John W. Richard III and Philip Raskin).
10 Is there a role for incretin-based therapy in combination with insulin? (Matheni Sathananthan and Adrian Vella).
11 HbA1c: Is it the most important therapeutic target in outpatient management of diabetes? (Steven A. Smith).
Part III Management of Associated Risk Factors and Disease.
12 Primary therapy for obesity as the treatment of type 2 diabetes (Manpreet S. Mundi and Michael D. Jensen).
13 Are statins the optimal therapy for cardiovascular risk in patients with diabetes? Are triglycerides an important independent risk factor for diabetes? (Michael O'Reilly and Timothy O'Brien).
14 The role of bariatric surgery in obese patients with diabetes: Primary or rescue therapy? (Praveena Gandikota and Blandine Laferrere).
15 Hyperglycemia should be avoided in critical illness and the postoperative period (Kalpana Muthusamy and John M. Miles).
16 Is there an optimal revascularization strategy in diabetic patients with ischemic heart disease? (Stephen H. McKellar, Morgan L. Brown, and Robert L. Frye).
Index.
